Regenxbio (RGNX) Receivables - Net (2016 - 2025)
Regenxbio (RGNX) has 12 years of Receivables - Net data on record, last reported at $28.7 million in Q4 2025.
- For Q4 2025, Receivables - Net rose 44040.0% year-over-year to $28.7 million; the TTM value through Dec 2025 reached $28.7 million, up 44040.0%, while the annual FY2025 figure was $28.7 million, 36.97% up from the prior year.
- Receivables - Net reached $28.7 million in Q4 2025 per RGNX's latest filing, up from $28.1 million in the prior quarter.
- Across five years, Receivables - Net topped out at $48.7 million in Q3 2021 and bottomed at $65000.0 in Q4 2024.
- Average Receivables - Net over 5 years is $28.3 million, with a median of $28.4 million recorded in 2025.
- Peak YoY movement for Receivables - Net: crashed 99.75% in 2024, then surged 44040.0% in 2025.
- A 5-year view of Receivables - Net shows it stood at $34.7 million in 2021, then decreased by 14.74% to $29.6 million in 2022, then decreased by 13.84% to $25.5 million in 2023, then plummeted by 99.75% to $65000.0 in 2024, then soared by 44040.0% to $28.7 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $28.7 million in Q4 2025, $28.1 million in Q3 2025, and $21.8 million in Q2 2025.